+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

From
From
From
Toxicology Testing Services - Global Strategic Business Report - Product Thumbnail Image

Toxicology Testing Services - Global Strategic Business Report

  • Report
  • December 2025
  • 273 Pages
  • Global
From
CAR T-cell Therapy - Global Strategic Business Report - Product Thumbnail Image

CAR T-cell Therapy - Global Strategic Business Report

  • Report
  • December 2025
  • 179 Pages
  • Global
From
Thin Film Drug Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Thin Film Drug Manufacturing - Global Strategic Business Report

  • Report
  • December 2025
  • 197 Pages
  • Global
From
Label-Free Detection - Global Strategic Business Report - Product Thumbnail Image

Label-Free Detection - Global Strategic Business Report

  • Report
  • December 2025
  • 384 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Thumbnail Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • December 2025
  • 192 Pages
  • Global
From
PEGylated Proteins - Global Strategic Business Report - Product Thumbnail Image

PEGylated Proteins - Global Strategic Business Report

  • Report
  • December 2025
  • 196 Pages
  • Global
From
Aptamers - Global Strategic Business Report - Product Thumbnail Image

Aptamers - Global Strategic Business Report

  • Report
  • December 2025
  • 179 Pages
  • Global
From
In Vitro Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

In Vitro Toxicology Testing - Global Strategic Business Report

  • Report
  • December 2025
  • 159 Pages
  • Global
From
Compound Management - Global Strategic Business Report - Product Thumbnail Image

Compound Management - Global Strategic Business Report

  • Report
  • December 2025
  • 194 Pages
  • Global
From
Biosimulation Technology - Global Strategic Business Report - Product Thumbnail Image

Biosimulation Technology - Global Strategic Business Report

  • Report
  • December 2025
  • 214 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 409 Pages
  • Global
From
High Content Screening (HCS) - Global Strategic Business Report - Product Thumbnail Image

High Content Screening (HCS) - Global Strategic Business Report

  • Report
  • December 2025
  • 183 Pages
  • Global
From
ADME-Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

ADME-Toxicology Testing - Global Strategic Business Report

  • Report
  • December 2025
  • 472 Pages
  • Global
From
Bioengineered Protein Drugs - Global Strategic Business Report - Product Thumbnail Image

Bioengineered Protein Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 193 Pages
  • Global
From
High Throughput Screening (HTS) - Global Strategic Business Report - Product Thumbnail Image

High Throughput Screening (HTS) - Global Strategic Business Report

  • Report
  • December 2025
  • 273 Pages
  • Global
From
Contract Research Outsourcing - Global Strategic Business Report - Product Thumbnail Image

Contract Research Outsourcing - Global Strategic Business Report

  • Report
  • December 2025
  • 453 Pages
  • Global
From
Drug Discovery Technologies - Global Strategic Business Report - Product Thumbnail Image

Drug Discovery Technologies - Global Strategic Business Report

  • Report
  • December 2025
  • 486 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more